Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 26Lymphoma, Non-Hodgkin 18Lymphoma 17Lymphoma, Follicular 15Lymphoma, Mantle-Cell 14Lymphoma, B-Cell, Marginal Zone 12Lymphoma, B-Cell 10Lymphoma, Large B-Cell, Diffuse 9Multiple Myeloma 8Leukemia 6Waldenstrom Macroglobulinemia 5Hodgkin Disease 5Neoplasms 4Sezary Syndrome 3Recurrence 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasm Metastasis 3Mycosis Fungoides 3Burkitt Lymphoma 3Neoplasms, Plasma Cell 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, T-Cell 2Lymphatic Diseases 2Leukemia, Myeloid, Acute 2Leukemia, Hairy Cell 2Immunoproliferative Disorders 2Immune System Diseases 2Brain Neoplasms 2Advanced Solid Tumor 2

Interventions

Irinotecan 2Bevacizumab 2pembrolizumab 1Vorinostat 1Thalidomide 1Nivolumab 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Neurologic Manifestations × Bendamustine Hydrochloride × Clear all
NCT00879073 2012-12-18

Study Bendamustine Concurrent Whole Brain Radiation Brain Metastases From Solid Tumors

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Terminated
12 enrolled
CNS

Brain Neoplasms, Neurologic Manifestations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡